Tofacitinib Ameliorates Lupus Through Suppression of T Cell Activation Mediated by TGF-Beta Type I Receptor
Qing Yan(Fujian Medical University), Lingyun Sun(Nanjing University of Chinese Medicine)
Cited by 31
Related Papers
A CD8 T Cell/Indoleamine 2,3‐Dioxygenase Axis Is Required for Mesenchymal Stem Cell Suppression of Human Systemic Lupus Erythematosus
|Arthritis & Rheumatology|2014|105
Umbilical Cord-Derived Mesenchymal Stem Cells Inhibit Cadherin-11 Expression by Fibroblast-Like Synoviocytes in Rheumatoid Arthritis
|Journal of Immunology Research|2015|51
Gene Expression Profile Reveals Abnormalities of Multiple Signaling Pathways in Mesenchymal Stem Cell Derived from Patients with Systemic Lupus Erythematosus
|Clinical and Developmental Immunology|2012|46
Efficacy and safety of mesenchymal stromal cell transplantation in the treatment of autoimmune and rheumatic immune diseases: a systematic review and meta-analysis of randomized controlled trials
|Stem Cell Research & Therapy|2025|25
Circulating miR-320b Contributes to CD4+ T-Cell Proliferation in Systemic Lupus Erythematosus via MAP3K1
|Journal of Immunology Research|2023|9